Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treprostinil controlled release - Camurus

Next Previous
Search
Drug Profile

Treprostinil controlled release - Camurus

Alternative Names: CAM 2043

Latest Information Update: 19 Jan 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Camurus
  • Class Acetic acids; Antifibrotics; Antihypertensives; Cyclopentanes; Naphthalenes; Prostaglandins; Skin disorder therapies; Small molecules; Vasodilators
  • Mechanism of Action Epoprostenol receptor agonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Raynaud's disease
  • Phase I Pulmonary arterial hypertension

Most Recent Events

  • 16 Jan 2024 Phase I development is ongoing for Pulmonary arterial hypertension in the US (Camurus pipeline, January 2024)
  • 28 May 2023 No recent reports of development identified for phase-I development in Pulmonary-arterial-hypertension(In volunteers) in USA (SC, Controlled release)
  • 24 May 2021 Treprostinil controlled release is still in phase I trials for Pulmonary arterial hypertension (In volunteers) in USA (SC, Controlled release) (Camurus pipeline, May 2021)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top